If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
People are focusing on the Antigen contract news due, but antibody tender announcements also due. Don't rule out the Elisa either, as home collection and lab test with results sent back will satisfy Regulator RE notifiable disease
Thanks responding MB, fair points.
The Abingdon general update to the market may result in a similar/ relative same time RNS by ODX just in relation to the Abc 19 test? Potentially interesting week ahead.
Its guessing games. No one on here or over there knows the answers or will know until information is released via RNS.
We are all headless chickens going round & round
Hi Okehurst hope you are well.
I’ve looked at recent comms from Avacta and I think they are subtly trying to detract from the idea idea that their test is high on gov priority.
Alex Shepherd Vatic ceo linked in profile is an interesting read.
I still come back to there is nothing any of the parties that you might think are involved can do that Mologic can’t. That’s why they all want to work with Mologic
I certainly think they have been making antibody tests whilst they wait to move forward with antigen.
I suspect TT delay is more to do with Mologic end rather than technical at ODX.
I think the time to deliver tests has been well known, why rush it, get validation right, use the time to carry on with antibody kits
Hi MB,
Suggest it’s a given we are increasing capacity up to 2M LFT’s a week come the end of the month ? It’s not Avacta’s that’s for sure as their test has not completed clinical validation nor cleared Porton Down.
Could we be manufacturing antibody tests for a Government contract whilst we await instructions on which Antigen Biotech is to be used ?
Or could we be manufacturing antigen test cassettes with the view to insert the nominated antigen biotech once advised by the Government?
The latter has some merits although I do appreciate its potentially double handling but we do hit the ground running ,we will of course get more of an idea if it’s the former next week when Abingdon update the market, ODX should in theory also separately advise on same day regards our own output and contribution to the Abc19 test .
What’s your opinion ?
2-5mins according to the website Matt;
https://www.vatic.health/how-it-works
I was wondering about the Vatic test.
Currently being trialled in Edinburgh Airport
https://www.med-technews.com/news/Covid-19-Medtech-News/edinburgh-airport-rapid-covid-19-testing-trial-to-determine-/
"PocDoc and BioSure are running the trial, delivering an end-to-end testing solution using the Vatic KnowNow saliva antigen test. "
https://www.biosure.co.uk/tests/covid-19-antigen-test/
It is not just Mologic test and Avacta test in the running......
Vatic is a highly credible test that appears to be going through a number of trials at the moment.
Mologic are working with Vatic. I believe the Vatic test is a direct competitor of the Avacta test, also being a spike protein test. There is a lot more evidence of progress and existence with this test, and the website and messaging is top drawer, ready for marketing roll out to public.
Omega are very well positioned here, they have the Mologic test to brand as their own and a government contract that if any other test is needed, they will make it.
It could be different tests are used in different circumstances.
Not long to go now i suspect until things become much clearer. Whatever is going on, ODX will be making 2m tests a week and selling the lot.
Interesting that the Surescreen test is "nasopharyngeal" and "anterior " only - ie not saliva
Goldtrig - AVCT as ODX, always think it is is about their test!
Avacta and Mologic will both fit that brief Goldtrig, true. Both under 15 mins. Both saliva aren't they? Good news. I'm clocking off. Going to try not to wish the weekend away. Have a good one everyone.
"Nasopharyngeal" is the bit right at the back of the nose.
"Oropharyngeal" is the bit right at the back of the throat, around the tonsils.
"Anterior nares" is the bit at the beginning of the nostrils
"Mid-turbinate" is basically the middle of the nasal passage.
What they're looking to do is making the method of collecting the sample less invasive and uncomfortable for those being swabbed. At present, most tests involve nasopharyngeal or oropharyngeal swabs which aren't very nice or easy to do... particularly for children or if you can't control your gag reflex.
The current UK developers will be able to adapt their tests to these sample types.
Its basically saying that new LFTs must be validated for use with nasal swabs or saliva sample types rather than the brain impalers we have been using.
Can someone explain the medical terms used please
"Sample type
DHSC will no longer validate lateral flow devices that only allow for a nasopharyngeal or oropharyngeal specimen collection method or both. Instead, the instructions for use (IFU) for the lateral flow device must contain a specimen collection method that allows for one or more of the following sample types:
anterior nares
mid-turbinate
saliva
This list is written in priority order: lateral flow devices submitted with a specimen collection method higher up on the list will be prioritised for validation. A lateral flow device will only be considered for validation when all lateral flow devices with a higher priority specimen collection method have been considered for validation.
Other sample types, which are not included in the list above, will be evaluated on a case by case basis."